Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda

Showing 15 posts of 249 posts found.

shire_image

Takeda moots Shire move but big questions remain

March 28, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

Takeda is considering making a bold move for Shire, after announcing, as per UK regulations, that it may make an …

News
european_commission_web

Takeda and TiGenix’s Alofisel becomes first donor-derived stem cell therapy approved in Europe

March 26, 2018
Sales and Marketing Crohn’s disease, EU, Europe, European Commission, Takeda, TiGenix, crohn's disease, pharma

The European Commission has awarded approval to Takeda and TiGenix’s allogeneic expanded adipose-derived stem cell (eASC) therapy Alofisel (darvadstrocel) for …

News
takeda_global_hq

Takeda completes construction of new global headquarters in Tokyo

March 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …

News
saroukos

Takeda’s CFO departs forcing company to act

March 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …

Appointment
top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …

News
takeda_usa_pharmaceuticals_u

Takeda to create 70 jobs with €25m Dublin investment

March 1, 2018
Manufacturing and Production Dublin, Takeda, pharma

Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a …

News
fuji

Fujifilm partners with Takeda, stepping into regenerative medicine

February 9, 2018
Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical

Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …

News

Takeda agrees $630m takeover of TiGenix

January 5, 2018
Medical Communications, Sales and Marketing Takeda, TiGenix, biotech, drugs, pharma, pharmaceutical

Takeda already had a strong working relationship with TiGenix, after previously signing a licensing agreement with the Belgium-based pharma company …

News
vaccination-2722937_960_720

The race to find an effective dengue vaccine

December 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, dengue, drugs, pharma, pharmaceutical

Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine …

Feature
china_block_001_takeda

Takeda’s dengue vaccine surpasses Sanofi’s in P2 trial

November 7, 2017
Manufacturing and Production, Sales and Marketing Sanofi, Takeda, biotech, drugs, pharma, pharmaceutical

Sanofi spent more than $1.5 billion and two decades to develop the first ever vaccine for dengue fever, only a …

News

Overcoming real-world challenges to maximise the benefit of treatment for patients with multiple myeloma

October 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, multiple myeloma

Dr Antonio Palumbo, Distinguished Research Fellow Oncology, Takeda Pharmaceuticals addresses hwo far we’ve come in treating multiple myeloma, and how …

Feature

Takeda’s Ninlaro knocked back by NICE for second time

September 5, 2017
Research and Development, Sales and Marketing Ninlaro, Takeda, biotech, drugs, pharma, pharmaceutical

NICE has revealed that the outcome of its consultation process for Ninlaro (ixazomib), Takeda’s treatment for relapsed or refractory multiple …

News
entrance_takeda_i020_v1

Takeda partners up to develop “next generation” CAR T solid tumour therapy

September 4, 2017
Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals

Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …

News
pharmafocus_september_2017_cover

The September 2017 issue of Pharmafocus is now live!

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma

The September edition of Pharmafocus is now available – click here to read online.

News
astrazeneca_logo_building

AstraZeneca unloads another drug for $400m

August 29, 2017
Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical

AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026